Literature DB >> 15850587

Distribution of brain atrophy in behavioral variant frontotemporal dementia.

Jillian J Kril1, Virginia Macdonald, Smita Patel, Francoise Png, Glenda M Halliday.   

Abstract

Marked brain atrophy occurs in frontotemporal dementia (FTD) yet substantial variation between cases is seen. Recently, a four-level staging scheme which reflects increasing disease duration, severity of dementia and degree of neurodegeneration was described. In the present study, the extent and magnitude of atrophy in behavioral variant FTD and its relationship to disease duration and pathological subtype was further evaluated by quantifying the volume of 30 anatomically-defined regions. A validated point count technique was applied to 17 patients with FTD (9 Pick's disease, 6 dementia lacking distinctive histology, 2 FTD with motor neuron disease) and 21 controls. Atrophy was seen in all brain regions except the inferior frontal cortex and area 37. As might be expected, increasing severity of atrophy occurred with increasing disease duration and stage however measurable atrophy was more widespread than indicated by the staging scheme. Furthermore, severity of atrophy was not related to pathological subtype. Frontal, limbic and temporal regions appeared to be severely affected early in the disease process with temporal lobe atrophy the best predictor of disease duration. White matter, more posterior regions and the subcortex were affected later in the disease. These findings demonstrate a pattern of selective vulnerability which progresses over time. Furthermore, they demonstrate that although patients with a similar clinical subtype may have differing underlying histopathology, the pattern, severity and progression of brain atrophy is the same. This suggests that the regional pattern of neurodegeneration, rather than the type of histopathology influences the clinical syndrome in FTD.

Entities:  

Mesh:

Year:  2005        PMID: 15850587     DOI: 10.1016/j.jns.2005.02.003

Source DB:  PubMed          Journal:  J Neurol Sci        ISSN: 0022-510X            Impact factor:   3.181


  31 in total

1.  Antemortem differential diagnosis of dementia pathology using structural MRI: Differential-STAND.

Authors:  Prashanthi Vemuri; Gyorgy Simon; Kejal Kantarci; Jennifer L Whitwell; Matthew L Senjem; Scott A Przybelski; Jeffrey L Gunter; Keith A Josephs; David S Knopman; Bradley F Boeve; Tanis J Ferman; Dennis W Dickson; Joseph E Parisi; Ronald C Petersen; Clifford R Jack
Journal:  Neuroimage       Date:  2010-12-31       Impact factor: 6.556

Review 2.  Frontotemporal dementia.

Authors:  Erik D Roberson
Journal:  Curr Neurol Neurosci Rep       Date:  2006-11       Impact factor: 5.081

3.  Patterns of striatal degeneration in frontotemporal dementia.

Authors:  Cathra Halabi; Anasheh Halabi; David L Dean; Pei-Ning Wang; Adam L Boxer; John Q Trojanowski; Stephen J Dearmond; Bruce L Miller; Joel H Kramer; William W Seeley
Journal:  Alzheimer Dis Assoc Disord       Date:  2013 Jan-Mar       Impact factor: 2.703

4.  MRI signatures of brain macrostructural atrophy and microstructural degradation in frontotemporal lobar degeneration subtypes.

Authors:  Yu Zhang; Maria Carmela Tartaglia; Norbert Schuff; Gloria C Chiang; Christopher Ching; Howard J Rosen; Maria Luisa Gorno-Tempini; Bruce L Miller; Michael W Weiner
Journal:  J Alzheimers Dis       Date:  2013       Impact factor: 4.472

Review 5.  The behavioral variant of frontotemporal dementia: linking neuropathology to social cognition.

Authors:  Chiara Cerami; Stefano F Cappa
Journal:  Neurol Sci       Date:  2013-02-03       Impact factor: 3.307

6.  Sequential distribution of pTDP-43 pathology in behavioral variant frontotemporal dementia (bvFTD).

Authors:  Johannes Brettschneider; Kelly Del Tredici; David J Irwin; Murray Grossman; John L Robinson; Jon B Toledo; Lubin Fang; Vivianna M Van Deerlin; Albert C Ludolph; Virginia M-Y Lee; Heiko Braak; John Q Trojanowski
Journal:  Acta Neuropathol       Date:  2014-01-10       Impact factor: 17.088

7.  Thiamine in the management of alcohol use disorders.

Authors:  Shima Shakory
Journal:  Can Fam Physician       Date:  2020-03       Impact factor: 3.275

8.  Pathophysiology of the behavioral variant of frontotemporal lobar degeneration: A study combining MRI and FDG-PET.

Authors:  M-S Buhour; F Doidy; M Laisney; A L Pitel; V de La Sayette; F Viader; F Eustache; B Desgranges
Journal:  Brain Imaging Behav       Date:  2017-02       Impact factor: 3.978

9.  Pathological staging of frontotemporal lobar degeneration.

Authors:  Jillian J Kril; Glenda M Halliday
Journal:  J Mol Neurosci       Date:  2011-05-07       Impact factor: 3.444

10.  Efficacy of memantine on neuropsychiatric symptoms associated with the severity of behavioral variant frontotemporal dementia: A six-month, open-label, self-controlled clinical trial.

Authors:  Pan Li; Wei Quan; Yu-Ying Zhou; Yan Wang; Hui-Hong Zhang; Shuai Liu
Journal:  Exp Ther Med       Date:  2016-04-20       Impact factor: 2.447

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.